JP2004502674A5 - - Google Patents

Download PDF

Info

Publication number
JP2004502674A5
JP2004502674A5 JP2002507781A JP2002507781A JP2004502674A5 JP 2004502674 A5 JP2004502674 A5 JP 2004502674A5 JP 2002507781 A JP2002507781 A JP 2002507781A JP 2002507781 A JP2002507781 A JP 2002507781A JP 2004502674 A5 JP2004502674 A5 JP 2004502674A5
Authority
JP
Japan
Prior art keywords
methyl
isopropyl
pyridyl
pyrrole
dichlorophenylthio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002507781A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004502674A (ja
Filing date
Publication date
Priority claimed from GBGB0016453.3A external-priority patent/GB0016453D0/en
Application filed filed Critical
Publication of JP2004502674A publication Critical patent/JP2004502674A/ja
Publication of JP2004502674A5 publication Critical patent/JP2004502674A5/ja
Pending legal-status Critical Current

Links

JP2002507781A 2000-07-04 2001-04-30 エイズを治療するためのピロール誘導体 Pending JP2004502674A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0016453.3A GB0016453D0 (en) 2000-07-04 2000-07-04 Pyrrole derivatives
PCT/EP2001/004832 WO2002002524A1 (en) 2000-07-04 2001-04-30 Pyrrole derivatives for treating aids

Publications (2)

Publication Number Publication Date
JP2004502674A JP2004502674A (ja) 2004-01-29
JP2004502674A5 true JP2004502674A5 (cg-RX-API-DMAC7.html) 2005-02-24

Family

ID=9895031

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002507781A Pending JP2004502674A (ja) 2000-07-04 2001-04-30 エイズを治療するためのピロール誘導体

Country Status (17)

Country Link
US (1) US6737429B2 (cg-RX-API-DMAC7.html)
EP (1) EP1301481A1 (cg-RX-API-DMAC7.html)
JP (1) JP2004502674A (cg-RX-API-DMAC7.html)
KR (1) KR100549884B1 (cg-RX-API-DMAC7.html)
CN (1) CN1440385A (cg-RX-API-DMAC7.html)
AR (1) AR028602A1 (cg-RX-API-DMAC7.html)
AU (2) AU6387401A (cg-RX-API-DMAC7.html)
BR (1) BR0112241A (cg-RX-API-DMAC7.html)
CA (1) CA2412270A1 (cg-RX-API-DMAC7.html)
EC (1) ECSP014109A (cg-RX-API-DMAC7.html)
GB (1) GB0016453D0 (cg-RX-API-DMAC7.html)
GT (1) GT200100111A (cg-RX-API-DMAC7.html)
MX (1) MXPA02012409A (cg-RX-API-DMAC7.html)
PA (1) PA8516201A1 (cg-RX-API-DMAC7.html)
PE (1) PE20020269A1 (cg-RX-API-DMAC7.html)
UY (1) UY26720A1 (cg-RX-API-DMAC7.html)
WO (1) WO2002002524A1 (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1405849A1 (en) * 2002-10-04 2004-04-07 Corning Incorporated Halogenated styrene compounds and low-absorption-loss polymers obtainable therefrom
KR101122708B1 (ko) 2003-12-26 2012-03-26 마사토시 하기와라 Sr 단백질 인산화 제어 방법, 및 유효성분으로서 sr 단백질 활성 제어제를 함유하는 항바이러스제
JP5173192B2 (ja) 2004-09-30 2013-03-27 武田薬品工業株式会社 プロトンポンプ阻害薬
TW200628446A (en) * 2004-12-14 2006-08-16 Takeda Pharmaceuticals Co Substituted pyrrole derivative
WO2006072833A1 (en) * 2005-01-06 2006-07-13 Pfizer Limited Imidazole derivatives as enzyme reverse transcriptase modulators
UA94424C2 (en) 2005-08-30 2011-05-10 Такеда Фармасьютикал Компани Лимитед 1-heterocyclylsulfonyl, 2-aminomethyl, 5-(hetero-)aryl substituted 1-h-pyrrole derivatives as acid secretion inhibitors
EP2076492A4 (en) * 2006-10-06 2010-12-22 Merck Sharp & Dohme NON-NUCLEOSIDIC REVERSE TRANSCRIPTASE INHIBITORS
CA2669675A1 (en) * 2006-11-10 2008-05-15 Syndax Pharmaceuticals, Inc. Combination of er.alpha.+ ligands and histone deacetylase inhibitors for the treatment of cancer
US8933105B2 (en) 2007-02-28 2015-01-13 Takeda Pharmaceutical Company Limited Pyrrole compounds
WO2009015180A2 (en) * 2007-07-23 2009-01-29 Syndax Pharmaceuticals, Inc. Novel compounds and methods of using them
WO2009050977A1 (en) * 2007-10-16 2009-04-23 Nikon Corporation Illumination optical system, exposure apparatus, and device manufacturing method
WO2009067453A1 (en) * 2007-11-19 2009-05-28 Syndax Pharmaceuticals, Inc. Combinations of hdac inhibitors and proteasome inhibitors
DK2318390T3 (da) 2008-08-27 2013-07-08 Takeda Pharmaceutical Pyrrolforbindelser
GB0823001D0 (en) * 2008-12-17 2009-01-28 Syngenta Participations Ag Thiophene,furan and pyrrole derivatives with plant growth regulating properties
CN101775011B (zh) * 2009-01-13 2013-07-31 中国人民解放军军事医学科学院毒物药物研究所 N-取代苯基-3-甲烯杂环芳烃-2,5-二甲基吡咯类化合物及其抗hiv/aids的应用
EP4061360A4 (en) * 2019-11-19 2023-07-05 New York Blood Center, Inc. SUBSTITUTED HETEROCYCLIC COMPOUNDS SHOWING THERAPEUTIC ACTIVITY AGAINST HIV

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3644631A (en) * 1969-05-13 1972-02-22 Endo Lab Therapeutic methods utilizing aryl pyrrol-3-yl ketones
US4282242A (en) * 1980-03-07 1981-08-04 Pfizer Inc. Antidiabetic pyrrolecarboxylic acids
US4347186A (en) * 1980-10-20 1982-08-31 Syntex (U.S.A.) Inc. Process for preparing 5-aroyl 1,2-dihydro-3-H pyrrolo[1,2-a]pyrrole-1-carboxylic acids and novel intermediates therein
ATE187451T1 (de) * 1992-12-17 1999-12-15 Pfizer Substituierte pyrazole als crf antagonisten
US5968944A (en) * 1994-06-06 1999-10-19 Pfizer Inc. Substituted pyrazoles as corticotropin-releasing factor (CRF) antagonists
TW406075B (en) * 1994-12-13 2000-09-21 Upjohn Co Alkyl substituted piperidinyl and piperazinyl anti-AIDS compounds
EP0912548A1 (en) * 1996-07-11 1999-05-06 Pfizer Inc. Pyridylpyrrole compounds useful as interleukin- and tnf antagonists
DE19963174A1 (de) * 1999-12-27 2001-07-12 Gruenenthal Gmbh Substituierte Pyrrol-Mannichbasen

Similar Documents

Publication Publication Date Title
JP2004502674A5 (cg-RX-API-DMAC7.html)
RU2425838C2 (ru) Ингибиторы iap
JP2008502700A5 (cg-RX-API-DMAC7.html)
RU2312105C9 (ru) N-пиразинилфенилсульфонамиды и их применение при лечении опосредованных хемокинами заболеваний
RU2439068C2 (ru) Модуляторы mglur5
RU97107997A (ru) Соединения дигалогенпропена, содержащие их инсектицидно/акарицидные агенты, и интермедиаты для их получения
JP2019518036A5 (cg-RX-API-DMAC7.html)
JP2013516415A5 (cg-RX-API-DMAC7.html)
RU2007117913A (ru) 2, 6-замещенные-4-монозамещенный амино-пиримидины как антагонисты рецептора простагландина d2
JP2012506446A5 (cg-RX-API-DMAC7.html)
JP2010540462A5 (cg-RX-API-DMAC7.html)
JP2020516671A5 (cg-RX-API-DMAC7.html)
JP2004517080A5 (cg-RX-API-DMAC7.html)
JP2010513304A5 (cg-RX-API-DMAC7.html)
JP2010529991A5 (cg-RX-API-DMAC7.html)
JP2007508346A5 (cg-RX-API-DMAC7.html)
JP2019537603A5 (cg-RX-API-DMAC7.html)
RU2003112610A (ru) Производные пиразола для лечения вирксных заболеваний
JP2006500369A5 (cg-RX-API-DMAC7.html)
JP2007308471A5 (cg-RX-API-DMAC7.html)
JP2004511469A5 (cg-RX-API-DMAC7.html)
JP2011500679A5 (cg-RX-API-DMAC7.html)
JP2020532589A5 (cg-RX-API-DMAC7.html)
JP2023062064A5 (cg-RX-API-DMAC7.html)
RU2348616C2 (ru) Новые пиперидины в качестве модуляторов хемокинов (ccr)